Navigation Links
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Date:7/8/2008

part of a total treatment program for ADHD that may include other measures (e.g., psychological, educational, social) for patients with this syndrome.

Important Safety Information

The most common adverse events seen with Focalin XR were dyspepsia, decreased appetite, headache and anxiety in pediatric studies; and dry mouth, dyspepsia, feeling jittery, dizziness, headache and anxiety in adult studies.

Focalin XR is contraindicated in patients with marked anxiety, tension and agitation since the drug may aggravate these symptoms; in patients known to be hypersensitive to methylphenidate or other components of the product; in patients with glaucoma; in patients with motor tics or with a family history or diagnosis of Tourette's syndrome; and during or following treatment with monoamine oxidase inhibitors.

Stimulants should generally not be used in children, adolescents or adults with known serious structural cardiac abnormalities, cardiomyopathy, serious heart-rhythm abnormalities or other serious cardiac problems. Use with caution in treating patients with underlying medical conditions that might be compromised by increases in blood pressure or heart rate, such as those with pre-existing hypertension, heart failure, recent myocardial infarction or ventricular arrhythmia. Before initiating treatment, patients should have careful history and physical exam to assess for presence of cardiac disease.

Use with caution in psychosis or bipolar disorder. Discontinuation of treatment may be appropriate in the presence of treatment-emergent psychotic or manic symptoms. While aggressive behavior is often observed in children or adolescents with ADHD, patients beginning treatment should be monitored for the appearance of or worsening of aggressive behavior or hostility.

Suppression of growth has been reported with long-term use of stimulants. Stimulants should be used with caution in patients with a prior history of seizures or EEG abnorm
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
2. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
3. New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Calif. , May 20, 2013   Life ... announced that its Applied Biosystems™ 3500 Dx and 3500xL ... Commission for Protection against Health Risks in ... a major extension of Life Technologies, capabilities to serve ... with Sanger -based solutions.  ...
(Date:5/20/2013)... BETHESDA, Md. , May 20, 2013  TNI ... diseases through the activation and mobilization of the body,s ... trading on the OTC Markets, OTCQB marketplace under the ... able to view the real-time Level II stock quotes ... Noreen Griffin , CEO of TNI BioTech, ...
(Date:5/20/2013)... 2013 Decision Resources, one of the ... and healthcare issues, finds that surveyed U.S. and ... effect on quality of life is among the ... level of subjectivity and variability of tests used ... state that it is difficult to differentiate therapies ...
Breaking Medicine Technology:Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2
... , CINCINNATI, Sept. 11 Kendle (Nasdaq: ... research organization, today announced that its regulatory affairs experts ... the Regulatory Affairs Professionals Society (RAPS) Annual Conference and ... Convention Center in Philadelphia. Demonstrating its leadership position in ...
... , , ... schedule of events at the Cardiovascular Research Foundation,s (CRF) annual ... 21st to Friday, September 25th, in San Francisco, CA. at ... world,s largest events for those performing cardiac diagnostics and interventions. ...
Cached Medicine Technology:Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition 2Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition 3InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting 2
(Date:5/20/2013)... May 20, 2013 This summer, digital ... world will make the pilgrimage to San Diego, CA, ... Digital Health Summer Summit produced by Living ... unique forum to showcase the latest digital health innovations, ... and network with some of industry’s most brilliant thinkers ...
(Date:5/20/2013)... 2013 Adeptia Inc., a ... business process integration solutions, today announced the ... integration solution. Version 6.0 is the ... automates business processes involving data access, validation, ... user interaction for real-time decision-making and exception-handling. ...
(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- Although many ... physician on staff to help improve outcomes, new ... to patients. Since one-third of teaching hospitals ... in Europe staff a nighttime physician in the ... while siphoning doctors away from hospitals with fewer ...
(Date:5/20/2013)... In celebration of National Women’s Health ... achieved at The Feinstein Institute for Medical Research ... Advancing Women in Science and Medicine (AWSM) , hosted ... Scientists, educators, business and community leaders from the region ... women in science. , “Women face unique barriers ...
(Date:5/20/2013)... it about toothpaste that transforms the sweet flavor of ... to that mysterious sensory phenomenon in colorful, animated ... Chemical Society,s award-winning Bytesize Science video series ... world,s largest scientific society, explains that the mainstay ingredients ... or SLS for short. When you brush your teeth, ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3
... Childhood obesity can lead to type 2 diabetes, asthma, ... youth are likely to be obese as adults, experience ... incur higher healthcare costs. In an article published in ... of Preventive Medicine, researchers report that children living ...
... Oct. 27 HealthSouth,Corporation (NYSE: HLS ) today, ... is reaffirming its previously announced full year 2008,guidance and ... believes remain sound., In addition, HealthSouth noted the ... million in debt year to date,through October 27, 2008, ...
... Oct. 27 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) ... annual,BIO Investor Forum on Thursday, October 30, 2008 at ... in San Francisco, California., Steve Worland, Ph.D., President ... of Anadys and an update on its development,programs., ...
... Mich. To tackle the growing number of psychiatric cases in ... of Michigan State University doctors from the colleges of Osteopathic ... across the state via video conference. , On a ... up to 10 patients each from as far away as ...
... ANN ARBOR, Mich., Oct. 27 Parrish Medical ... implemented Clinical,Xpert CareFocus(TM) and Clinical Xpert Navigator which ... workflow solutions from the Healthcare business of,Thomson Reuters., ... patients,within a hospital and give clinicians access to ...
... even in combo, an effective long-term treatment , , MONDAY, ... methotrexate are safe and effective for long-term, continuous treatment ... In a three-year study that enrolled about 600 patients, ... methotrexate alone, others took etanercept alone, and another group ...
Cached Medicine News:Health News:Green neighborhoods may reduce childhood obesity 2Health News:HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance 2Health News:HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance 3Health News:Anadys Pharmaceuticals to Present at Bio Investor Forum 2Health News:MSU doctors bring much-needed psychiatric care to rural areas via technology 2Health News:Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters 2Health News:Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters 3Health News:Etanercept, Methotrexate Safe for Juvenile RA 2
Troutman tying forceps are curved, delicate, bullet shape, with tying platforms. Flat pattern. Ultra fine platforms ideal for 10-0 or 11-0 suture material. Platforms fully meet to hold suture firmly....
Fine tying forceps, standard with smooth jaws. For 7-0 to 9-0 sutures....
Tennant stainless steel tying forceps is extra delicate, straight with smooth jaws, 6 mm long platform, round handle with guide pin. For 9-0 to 11-0 sutures....
Curved shafts and tips with tying surfaces. Wide serrated handle with dull finish. Overall length 4.3 inches....
Medicine Products: